Latest news with #IVIRMAGlobal
Economic Times
8 hours ago
- Business
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
Yahoo
16-04-2025
- Health
- Yahoo
Reproductive Medicine Associates Offers $30 Mini Consults Throughout April in Recognition of National Infertility Awareness Week
Affordable 20-minute telehealth consultations in select New Jersey, Northern California, Colorado and Pennsylvania clinics will help individuals and couples begin their family building journeys BASKING RIDGE, N.J., April 16, 2025--(BUSINESS WIRE)--Reproductive Medicine Associates, one of the nation's leading reproductive service providers and a pioneer in IVF research, is offering $30 fertility consultations throughout the month of April in recognition of National Infertility Awareness Week (NIAW), April 20-26th, 2025. These 20-minute telehealth meetings with a fertility expert will provide individuals and couples with an affordable opportunity to discuss their family building plans and gain valuable insight into fertility preservation and treatment options. Consultations will be offered in select New Jersey, Northern California, Colorado and Pennsylvania clinics to new patients. "With these mini consults, we hope to make fertility care more accessible and help individuals and couples take the most important step toward achieving their family building goals – the first one," said Dr. Thomas Molinaro, Chief Medical Officer and Reproductive Endocrinologist. "Knowledge is power. Many Americans wait too long before they seek professional help, but early guidance can have a positive impact on outcomes." Founded in 1989 by RESOLVE: The National Infertility Association, the goal of NIAW is to increase public awareness and understanding of infertility issues through education, empowering individuals and communities to change the conversation around infertility. "National Infertility Awareness Week brings much-needed attention to the far-reaching impact of infertility and the challenges roughly one in six Americans experience when trying to conceive," added Lynn Mason, CEO of IVI RMA North America. "We are proud to offer these mini consultations during the month of April to increase access to fertility care." To learn more and schedule a consultation with an RMA fertility expert, visit About IVI RMA North AmericaIVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, Toronto-based TRIO, and Pearl Mini-IVF Fertility Clinic in San Diego, spans 22 IVF laboratories and has helped women achieve pregnancies which have led to the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. Part of IVI RMA Global, one of the world's leading Reproductive Medicine groups committed to providing evidence-based fertility solutions with the greatest chance of success in the shortest time necessary to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 5,100 people across 200+ ART clinics in 15 countries. The group sees more than 115,000 patients per year, performing 180,000 annual treatments. Learn more at and View source version on Contacts Media Contact Cindi Goodsellcgoodsell@ 510-409-3646 Sign in to access your portfolio
